{
    "nct_id": "NCT03303846",
    "official_title": "Combined Breast MRI/Biomarker Strategies to Identify Aggressive Biology",
    "inclusion_criteria": "* Women who are undergoing screening breast MRI as per standard of care for high-risk breast cancer screening\n* Willing to donate left-over tissue if patient undergoes a breast biopsy and/or breast surgery\n* Willing to have about 40 mL of blood (approximately 3 tablespoons) drawn\n* Documented informed consent of the participant\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Allergy or intolerance to gadolinium\n* Inability to undergo breast MRI (e.g. claustrophobia)\n* Participants with active cancer diagnosis (exception: skin cancer, biopsy-proven atypical lobular, ductal hyperplasia and/or lobular carcinoma in situ)\n* Previous diagnosis of stage 4 cancer\n* Participants who have received cytotoxic chemotherapy within 1 year prior to screening breast MRI\n* Participants who have received endocrine therapy within 1 year prior to screening breast MRI\n* Participants who have received breast radiation within 1 year prior to screening breast MRI\n* Radiation to both breasts\n* Pregnant and/or lactating within 1 year prior to screening breast MRI\n* Receives screening breast MRIs at an outside facility other than the consenting institution",
    "miscellaneous_criteria": ""
}